当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析

南微医学

(688029)

  

流通市值:136.49亿  总市值:136.49亿
流通股本:1.88亿   总股本:1.88亿

南微医学(688029)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润1.47亿元,每股收益0.76元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益378355.38万元,未分配利润153525.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产437742.80万元,负债59387.42万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入620,078,643.582,411,468,385.361,745,324,768.571,147,134,950.13
营业总成本447,485,577.571,854,314,053.61,293,258,893.85827,845,546.38
营业利润172,959,026.14554,669,145.48457,816,323.12317,244,262.97
利润总额173,708,520.78564,909,917.62455,359,714.69314,146,040.88
净利润147,454,778.74494,700,551.52395,076,681.45271,014,804.83
其他综合收益-4,059,448.592,085,032.26923,703.617,952,454.34
综合收益总额143,395,330.15496,785,583.78396,000,385.06278,967,259.17
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计3,208,432,794.63,290,807,580.173,147,058,408.543,104,045,850.04
非流动资产合计1,168,995,225.071,101,865,430.051,042,660,983.07994,250,996.83
资产总计4,377,428,019.674,392,673,010.224,189,719,391.614,098,296,846.87
流动负债合计518,072,344.28649,519,965.7551,778,654.94579,622,399.69
非流动负债合计75,801,905.0472,994,604.3268,512,074.666,278,911.04
负债合计593,874,249.32722,514,570.02620,290,729.54645,901,310.73
归属于母公司股东权益合计3,721,325,228.243,611,919,944.63,511,418,308.773,396,220,148.76
股东权益合计3,783,553,770.353,670,158,440.23,569,428,662.073,452,395,536.14
负债和股东权益合计4,377,428,019.674,392,673,010.224,189,719,391.614,098,296,846.87
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计671,676,490.272,547,213,926.111,791,077,407.191,223,096,176.71
经营活动现金流出小计615,950,912.542,001,639,165.141,431,899,449.69980,333,246.12
经营活动产生的现金流量净额55,725,577.73545,574,760.97359,177,957.5242,762,930.59
投资活动现金流入小计564,273,452.242,888,406,394.6997,115,514.58749,823,051.45
投资活动现金流出小计874,532,233.074,025,771,808.962,526,368,386.641,950,930,447.54
投资活动产生的现金流量净额-310,258,780.83-1,137,365,414.36-1,529,252,872.06-1,201,107,396.09
筹资活动现金流入小计-37,278,253.637,278,253.62,278,253.6
筹资活动现金流出小计32,802,158.67151,772,528.81110,166,573.81107,701,995.29
筹资活动产生的现金流量净额-32,802,158.67-114,494,275.21-72,888,320.21-105,423,741.69
汇率变动对现金及现金等价物的影响-10,349,349.940,186,688.6228,328,212.7152,494,628.96
现金及现金等价物净增加额-297,684,711.67-666,098,239.98-1,214,635,022.06-1,011,273,578.23
期末现金及现金等价物余额911,582,949.171,209,262,660.84660,725,878.76864,087,322.59
最新报告期:2024-04-28
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国泰君安丁丹,张拓3.243.964.812024-04-28
中金公司俞波,张琎3.324.06--2024-04-27
华泰证券代雯,孔垂岩,王殷杰3.294.255.502024-04-26
东吴证券朱国广3.264.105.152024-04-26
广发证券罗佳荣2.603.244.042024-02-25
TOP↑